HRB invests €3 million to make clinical trials more relevant, accessible and influential for all

Date 22nd July 2021: Continued funding of the HRB-Trial Methodology Research Network (HRB-TMRN) reinforces its important role in strengthening the methodology and reporting of trials in health and social care in Ireland.

Since 2014, the HRB-TMRN has been a key component of Health Research Board (HRB)-funded clinical research infrastructure, working in harmony with Clinical Research Facilities/Centres, Clinical Trial Networks and the HRB National Clinical Trials Office.

Welcoming the new investment, Dr Mairéad O’Driscoll, CEO of the HRB said:

“The HRB-TMRN has excelled in its mission to strengthen the methodology and reporting of trials to benefit patients, practitioners, policy makers and the public, and is now considered an exemplar of best practice in its field, with many groups learning from and referencing HRB-TMRN examples. The Health Research Board looks forward to continued success from this new round of investment.”

Read More>

Start typing and press Enter to search

X